For Authors

Authors of research articles should disclose at the time of submission any financial arrangement they may have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, the editors will usually discuss with the authors the manner in which such information is to be communicated to the reader.
Because the essence of reviews and editorials is selection and interpretation of the literature, the Journal expects that authors of such articles will not have any financial interest in a company (or its competitor) that makes a product discussed in the article. Publisher requires that reviewers, associate editors, editors, and senior editors reveal in a letter to the Editor-in-Chief any relationships that they have that could be construed as causing a conflict of interest with regard to a manuscript under review. The letter should include a statement of any financial relationships with commercial companies involved with a product under study.

The editors endorse the principles embodied in the Declaration of Helsinki and expect that all investigations involving humans will have been performed in accordance with these principles. For animal experimentation reported in the journal, it is expected that investigators will have observed the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing, and Education issued by the New York Academy of Sciences’ Adhoc Committee on Animal Research. All human and animal studies must have been approved by the investigator’s Institutional Review/Ethical Board. To ensure high-quality scientific publications, editorial board adhere to certain ethical standards. In the case of multi-authorship, the editorial board requires the affiliation and percentage of the creative contribution to the paper, specified for each author. The editorial board shall document all manifestations of scientific dishonesty (especially Ghostwriting and Guest Authorship, plagiarism in any form, appropriation of the scientific output, final conclusions); they shall be disclosed and notified to competent entities (to the institutions hiring the author, and to academic and publishing associations). „Double blind reviews” guarantee independence and lack of conflict of interest in the relationship between the reviewer and the author.

Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients’ names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance.